Cart
sales@molnova.com
HHQ
CAS No. 40522-46-1
HHQ( 2-heptylquinolin-4(1H)-one )
Catalog No. M27134 CAS No. 40522-46-1
HHQ is a PqsR antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 84 | In Stock |
|
| 2MG | 52 | In Stock |
|
| 5MG | 86 | In Stock |
|
| 10MG | 139 | In Stock |
|
| 25MG | 233 | In Stock |
|
| 50MG | 338 | In Stock |
|
| 100MG | 500 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHHQ
-
NoteResearch use only, not for human use.
-
Brief DescriptionHHQ is a PqsR antagonist.
-
DescriptionHHQ is a PqsR antagonist.
-
In Vitro——
-
In Vivo——
-
Synonyms2-heptylquinolin-4(1H)-one
-
PathwayOthers
-
TargetOther Targets
-
RecptorApoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number40522-46-1
-
Formula Weight243.35
-
Molecular FormulaC16H21NO
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCCCCc1cc(=O)c2ccccc2[nH]1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wu W, et, al. Millepachine showed novel antitumor effects in cisplatin-resistant human ovarian cancer through inhibiting drug efflux function of ATP-binding cassette transporters. Phytother Res. 2018 Dec; 32(12):2428-2435.
molnova catalog
related products
-
Methyl 5-hydroxy-1H-...
Methyl 5-hydroxy-1H-indole-3-carboxylate is a marine derived natural products found in Hyrtios erectus.
-
Lactucine
Lactucin (Standard) is the analytical standard of Lactucin. This product is intended for research and analytical applications. Lactucin is an anti-inflammatory agent. Lactucin induces cancer cell apoptosis. Lactucin also shows analgesic, anticancer and antimalarial activities.
-
Rhodamine 800
Rhodamine 800 is a near-infrared fluorescent dye. The absorption maximum at 683 nm in acetone shifts to 696 nm in DMSO without a significant change of the overall spectral profile.
